Gaurav Chandra M.D. @drgauravchandra Twitter profile

Last Seen Profiles

@Podruga_Kruga

@Chenthoorii

@soledad_dovic

@UNISON_Gaming_

@iiblackrabbit

@9vxfe

@Mario__Maurer

@xglygod

@chicken622

@sour_mamba

@LVTV_02

@101Haterology

@trendysubbox

@the_mls

@panya_nyan_da

@lalisamaximoff

@MEMS_Principal

@bokeplokalmalam

@byakuyanomadoka

@RingsideBatz

@tomaszhoskins

@badmoontalent

@p_nr78

@ihavquest

@oqum_

@HSBC_SG

@Coach_Zim24

@_sammymendez1

@AREEB_91K

@Tantemonik69

@Pau_0487

@SergeMaabe3

@stasistars

@michel_gamba_

@RizzlordSigma

@downerworld

Gaurav Chandra M.D.

@drgauravchandra

3 years

Enzolytics analyzed 2 million isolates and confirmed that the 19 sites against which it is producing #mabs are conserved in ALL the variants. Delta,Lambda, Alpha, Beta, & Gamma.ENZC Monoclonal Antibodies prevent "virus escape".Go for the #CURE #ENZC #AI

Company News - Enzolytics

ENZOLYTICS ANNOUNCES THE SIGNING OF THE BUSINESS COMBINATION AGREEMENT WITH SAGALIAM ACQUISITION CORP (SAGA) COLLEGE STATION, TX / ACCESSWIRE / September 5, 2023/ Enzolytics, Inc. (OTC PINK: ENZC)...

enzolytics.com

81

322

917

Gaurav Chandra M.D.

@drgauravchandra

4 years

With the emergence of variants of concern and concerns with Vaccine effectiveness in the face of viral mutations, Enzolytics comes up with a groundbreaking solution. Big news coming up next week. #SARS -CoV2 #mutations #AI #patents #innovation #monoclonalantibody #enzc

114

264

850

Gaurav Chandra M.D.

@drgauravchandra

3 years

"It takes a village to change the world" @samsungbiologi Welcome to the Enzolytics family #hiv #covid #monoclonal #antibodies

66

246

800

Gaurav Chandra M.D.

@drgauravchandra

3 years

ENZC strong. #ENZC

105

152

767

Gaurav Chandra M.D.

@drgauravchandra

4 years

Early next week launching our website with updates and new developments. #ENZC # Enzolytics #HIV #SARSCoV2

74

197

755

Gaurav Chandra M.D.

@drgauravchandra

3 years

Evolutionary biology will cause the virus to continue to mutate. Let us not chase mutations, use AI to identify them, and treat them with targeted Human Monoclonal Antibodies. At Enzolytics we continue to make rapid progress with the CURE. #ENZC #AI #COVID19 #HIV B.1.617.2 #mAb

39

202

703

Gaurav Chandra M.D.

@drgauravchandra

3 years

The fact that three weeks after your first dose of vaccine you are only 30% protected versus, in the original,you were 80% the virus is figuring evasion of the immune system. Stop chasing mutations target immutable targets. #delta #plus #variant #voc #ENZC #breakthrough #infection

39

171

706

Gaurav Chandra M.D.

@drgauravchandra

3 years

#ENZC It is our time to shine.Onwards and upwards.

Gaurav Chandra M.D.

@drgauravchandra

3 years

@mc_stocktrader Only the tip of the iceberg.

36

74

443

47

175

687

Gaurav Chandra M.D.

@drgauravchandra

3 years

Never lose sight of how far we have come, what we have achieved, the current and upcoming partnerships, upcoming milestones, and catalysts for the company. ALL the milestones will be achieved. Don't chase daily prices. We have a plan for success. #ENZCSTRONG #ENZC

56

169

685

Gaurav Chandra M.D.

@drgauravchandra

3 years

Enzolytics announces a coherent protocol to meet the Company's objective of a therapeutic cure for HIV and to address existing and future pandemics. A collaboration with Intel Corporation to accelerate health care discoveries and development. #ENZC #HIV #COVID #H10N3 #AI @IntelAI

21

219

675

Gaurav Chandra M.D.

@drgauravchandra

3 years

Enzolytics concludes plans to advance ITV-1 anti-HIV therapeutics to clinical trials and distribution throughout Europe. Completion of these steps will establish its anti-HIV therapy as a significant revenue source for the Company. #ENZC

42

210

674

Gaurav Chandra M.D.

@drgauravchandra

3 years

We Can We Will End of story.2022 just getting started #ENZC #sciencewillwin

53

156

682

Gaurav Chandra M.D.

@drgauravchandra

3 years

As promised joint press release on multiple platforms regarding thought leadership collaboration with Intel on 05/17/2021 . #ENZC #AI #iamintel #ai4good #HIV #COVID19 #mAb #leadership #treatingdeadlydisease #Disruptivetechnology #changehealthcare

45

199

644

Gaurav Chandra M.D.

@drgauravchandra

3 years

Enzolytics continues its onward and upward march towards strategic partnerships and a stronger Intellectual Property portfolio. #ENZC #HIV #COVID19 #AI #Gileads #EliLilly #Patent #Monoclonal #Antibodies #acquisition #partnership #immunome

37

194

633

Gaurav Chandra M.D.

@drgauravchandra

3 years

Enzolytics will be represented at the conference on 04/14 at 2:30 pm CT. Charles Cotropia will be sharing the company's innovations and vision in the field of immunotherapeutics. We have many exciting collaborations in the pipelines. Onwards and upwards. @EmergingGrowthC #ENZC

54

171

642

Gaurav Chandra M.D.

@drgauravchandra

3 years

Enzolytics announces definitive plans to advance our previously tested ITV-1 anti-HIV therapeutics to clinical trials and distribution throughout Europe. Definite steps in place to bring anti-HIV ITV-1 therapy to patients. #ENZC #HIV #ITV1 #revenue

47

180

633

Gaurav Chandra M.D.

@drgauravchandra

3 years

We now have a comprehensive platform for producing multiple targeted #mab against numerous infectious diseases. We are discussing #licensing , #commercialization , #partnership and distribution of these mabs with various pharmaceutical partners to expedite the development. #enzc

31

192

632

Gaurav Chandra M.D.

@drgauravchandra

3 years

Enzolytics has engaged a national marketing agency as its distributor to advance the Enzolytics IPF Immune™ through multiple distribution channels throughout the U.S and access the nutritional supplement market #ENZC #REVENUE #IPF #ENZCstrong

47

164

635

Gaurav Chandra M.D.

@drgauravchandra

2 years

We are excited to launch our website for Enzolytics #IPFImmune ™.Look for it on multiple online platforms, in MULTIPLE retail stores near you and online platforms. #ENZC #IPFIMMUNE Incoming #tsunami

61

179

639

Gaurav Chandra M.D.

@drgauravchandra

3 years

Enzolytics move forward rapidly with a strategic focus on revenues as we introduce Enzolytics IPF Immune to the North American market. #ENZC #REVENUE #immunemodulator

Enzolytics, Inc. Announces Production and Sale in North America of "Enzolytics IPF Immune", a...

www.accesswire.com

43

169

631

Gaurav Chandra M.D.

@drgauravchandra

3 years

@dwoodru11 @enzolytics Stop chasing daily prices. We have a plan for success.

58

102

624

Gaurav Chandra M.D.

@drgauravchandra

3 years

As we launch our patented Enzolytics IPF Immune™ in March 2022 will have the opportunity to meet privately with buyers from the country's large and small retail chains such as Amazon, CVS Health, GNC, & Walgreens. #ENZC

36

142

624

Gaurav Chandra M.D.

@drgauravchandra

3 years

9/16/20 A year today since the merger of Enzolytics with BioClonetics. It has been an inspirational year for the Enzolytics family. We started with a few, but now we are many—an incredible journey of belief and perseverance.Very excited about the future #ENZC #family #Thanks

44

104

598

Gaurav Chandra M.D.

@drgauravchandra

3 years

Don't stop believing. Today may be challenging, but tomorrow will be bright and sunny. #ENZC @enzolytics

85

121

598

Gaurav Chandra M.D.

@drgauravchandra

2 years

ITV-1 therapeutic will be made available in the countries in Africa, including Rwanda, the DRC, Angola, and Kenya. We are coordinating efforts to allow access to ITV-1 for 23.8 million infected individuals in all of Africa. #ENZC #ITV1 #HIV

56

204

594

Gaurav Chandra M.D.

@drgauravchandra

3 years

In a breakthrough, development Enzolytics announces that the monoclonal antibodies developed also target the variant strains from the UK, Brazil, and South Africa #ENZC #COVID #universal #durable #mAbs #vaccine #EmergingVariants #DoubleMutation

Coronavirus Targeted Epitopes Claimed in Enzolytics' Pending Patent Applications are Verified as...

www.accesswire.com

43

173

584

Gaurav Chandra M.D.

@drgauravchandra

3 years

Enzolytics and Intel publish thought leadership collaboration highlighting Intel’s AI Analytic tools, Enzolytic’s innovations and groundbreaking contributions to create universal, durable, and broadly effective treatment targeting virus. #ENZC #AI #Covid

Healthcare and Life Sciences Technology Solutions - Intel

Healthcare technology solutions powered by Intel use AI, connectivity, compute, and edge-to-cloud computing to realize the future of healthcare.

www.intel.com

49

172

576

Gaurav Chandra M.D.

@drgauravchandra

2 years

We continue to work hard in silence. Our success will be only the noise you hear as we march forward with multiple milestones and global partnerships. Expect an updated website soon. #ENZC

56

143

581

Gaurav Chandra M.D.

@drgauravchandra

3 years

Licensing and Commercialization of anti-HTLV-1 Monoclonal Antibodies to Creative Biolabs, Inc. Currently no effective treatment available for HTLV-1 .More partnerships to come. #ENZC #HTLV1 #MAB #AI #CURE #HIV #SARSCoV2 @creativebiolabs @enzolytics

23

151

572

Gaurav Chandra M.D.

@drgauravchandra

3 years

We take rapid strides in the development of Monoclonal Antibodies for Veterinary use. Phage Display technology to accelerate the antibody discovery process and create novel molecules that can lead to breakthroughs in technology and medicine. #ENZC #AI

26

157

566

Gaurav Chandra M.D.

@drgauravchandra

3 years

Enzolytics continues to work on a roadmap for utilizing AI to understand the current pandemic, develop novel treatment strategies, and pave the way for the prevention of future pandemics. #syndemic #HIV #COVID #H10N3 #ENZC #Future #AI #Digitalhealth #disruption #technology

19

133

564

Gaurav Chandra M.D.

@drgauravchandra

3 years

As Enzolytics continues to march forward with fulfilling its milestones, we also understand our AI platform's potential in synergizing Genetics, Microbiome, and Technology. Understanding this pandemic and preventing another one. #ENZC #Intel #microbiome #AI #covid #AIplatform

23

163

566

Gaurav Chandra M.D.

@drgauravchandra

3 years

AI platform to identify conserved, immutable, and neutralizable target sites (epitopes) on H10N3, Influenza A and B, H1N1 influenza, (RSV), Ebola, Small-Pox, Herpes zoster, Varicella zoster, Anthrax, and Rabies virus." Let us prevent the next pandemic #H10N3 #ENZC #Future #AI

16

167

550

Gaurav Chandra M.D.

@drgauravchandra

3 years

As Enzolytics continues to march forward to successful milestones we must remember to celebrate milestones thank all our partners as we prepare for the road ahead.The future is bright #AI #platform #hiv #covid #animal #mabs #microbiome #p4medicine #uplist #ENZC

36

130

552

Gaurav Chandra M.D.

@drgauravchandra

1 year

Life Science Review has acknowledged the Enzolytics team as one of the top companies for #monoclonal antibody solutions. This recognition is attributed to our unwavering dedication to utilizing advanced #AI technology to create effective treatments and diagnostic tools for

76

148

554

Gaurav Chandra M.D.

@drgauravchandra

3 years

AI is transforming healthcare, and those changes are happening now from the inside out at the microbiome level. It takes a village to change the world #microbiome #ENZC #ESTONIA #P4MEDICINE #personalizedmedicine #AI #ENZCstrong

#Enzolytics - The Intersection of Science and Technology - Using AI +...

Guests: Dr. Gaurav Chandra, COO, EnzolyticsRiin Ehin, CEO, Personalised Medicine Association, Estonia#microbiome #ai #enzolytics

www.youtube.com

33

135

526

Gaurav Chandra M.D.

@drgauravchandra

3 years

Enzolytics continues to make rapid progress with its comprehensive therapeutic protocol for production of Monoclonal Antibodies to address ongoing and future Pandemics.Onwards and Upwards #ENZC #HIV #Covid_19 #influenza #HTLV1 #AI #syndemic #mab #patents

27

149

526

Gaurav Chandra M.D.

@drgauravchandra

2 years

#AI -Empowered Intellectual Patent Portfolio solidifies Enzolytics' position (leverage) and opens up tremendous opportunities through partnering & licensing technology for diagnostics, therapeutics, and vaccines for all viruses in our portfolio. #ENZC

Enzolytics Announces the International Patent Office Search Report finding Novelty and Inventiven...

In the first Official Action on the Company's International Patent Application covering its discovery and exclusive claim to conserved antigens and epitopes of the HIV virus, the PCT International...

www.nasdaq.com

39

173

527

Gaurav Chandra M.D.

@drgauravchandra

3 years

Enzolytics Announces Its New Technology For Entry Into The In-Vitro Diagnostics Market. #ENZC is currently working with #diagnostic companies with track records for taking this technology produced through regulatory approval to patients. #2022 use. #IP #AI

Enzolytics Announces Its New Technology For Entry Into The In-Vitro Diagnostics Market

www.accesswire.com

25

142

530

Gaurav Chandra M.D.

@drgauravchandra

3 years

Let no feeling of discouragement prey upon you, and in the end, you are sure to succeed-Abraham Lincoln. Lots to achieve in 2021 as we march forward, fulfilling our milestones. #ENZC #ENZCstrong #animalmabs #immunemodulator #uplist #HIV #COVID #sciencewillwin

31

115

524

Gaurav Chandra M.D.

@drgauravchandra

3 years

We look forward to an exciting year as we rapidly progress with our ground-breaking treatments. We are as excited as our partners Samsung Biologics. #ENZC #HIV #SARSCOV2 #Mabs #2022

CDMO Samsung Biologics Prepares for a Fruitful and Exciting New Year

Samsung Biologics, a leading contract development and manufacturing organization (CDMO), looks forward to an exciting new year full of new partnerships and more expansions and services for their...

www.rushprnews.com

22

133

524

Gaurav Chandra M.D.

@drgauravchandra

2 years

Enzolytics announces the discovery of conserved target sites on the #monkeypox #virus as we march forward in our relentless pursuit of utilizing our proprietary comprehensive AI protocol to address future healthcare needs in pandemics. #AI #ENZC #patent

Enzolytics Announces the Discovery of Conserved Target Sites on the Monkeypox Virus

COLLEGE STATION, TX / ACCESSWIRE / June 21, 2022 / Enzolytics, Inc. (OTC PINK:ENZC) (ENZC" or the "Company") today announced it has identified conserved, immutable sites (epitopes) on the Monkeypox...

finance.yahoo.com

43

160

516

Gaurav Chandra M.D.

@drgauravchandra

3 years

Enzolytics, Inc. has engaged @scendea USA, Inc. (), with a strategic goal to advance its anti-HIV therapeutic ITV-1 to production, clinical trials, and market approval under both EMA and the FDA regulatory process. #ENZC #ITV1 #HIV

Company News - Enzolytics

ENZOLYTICS ANNOUNCES THE SIGNING OF THE BUSINESS COMBINATION AGREEMENT WITH SAGALIAM ACQUISITION CORP (SAGA) COLLEGE STATION, TX / ACCESSWIRE / September 5, 2023/ Enzolytics, Inc. (OTC PINK: ENZC)...

enzolytics.com

22

125

506

Gaurav Chandra M.D.

@drgauravchandra

3 years

Enzolytics and Intel Corporation has published a thought leadership collaboration. #ENZC #HIV #COVID #disruptivetechnology #Monoclonal #AI #AI4Good #AI4Good #Intel

Enzolytics Inc. and Intel Corporation Co-Author White Paper on Use of Artificial Intelligence for...

www.accesswire.com

15

123

499

Gaurav Chandra M.D.

@drgauravchandra

2 years

#ENZC moves expeditiously with our diagnostics and therapeutics for #HIV . We have made massive strides with our wholly-owned Subsidiary Virogentics towards clinical use of ITV-1 in Central and Eastern #Africa #Revenues #therapeutics #Diagnostics

Enzolytics, Inc.'s Wholly Owned Subsidiary Virogentics, Inc. Reports Progress on the Delivery of...

COLLEGE STATION, TX / ACCESSWIRE / March 14, 2022 / Enzolytics, Inc. (OTC PINK:ENZC) (https://enzolytics.

finance.yahoo.com

22

132

510

Gaurav Chandra M.D.

@drgauravchandra

3 years

We use AI to assess millions of virus sequences, identify the conserved sequences essential for virus survival. We harness AI's power with our Fully Human Monoclonal Antibody methodology, creating Universal, Durable, Broadly Neutralizing mAbs targeting all virus variants. #enzc

Gaurav Chandra M.D.

@drgauravchandra

3 years

As per our predictions, Cell published data indicate SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies induced by infection and vaccination. We have to target conserved sites. #ENZC #variantsofconcern #pandemic @CellCellPress

31

104

466

33

116

500

Gaurav Chandra M.D.

@drgauravchandra

2 years

Vision without action is merely a dream. Action without vision just passes the time. But, vision with action can change the world -Joel A Barker. #ENZC Lets change the world one therapy at a time #IPFImmune will be available on many online platforms and retail stores near you.

37

134

507

Gaurav Chandra M.D.

@drgauravchandra

3 years

Levels of neutralizing antibodies in recipients of BioNTech/Pfizer vaccine five times LOWER against the DELTA VARIANT than the original Wuhan strain. We had predicted this last year. Address the conserved sites and not chase mutations #ENZC #CURE #Mab #AI

Vulnerable people may need vaccine boosters this year, scientists say

Pfizer jab found to elicit lower antibody response to Delta variant than to original coronavirus strain

www.ft.com

22

161

496

Gaurav Chandra M.D.

@drgauravchandra

2 years

#ENZC welcomes Dr. Lachezar Bogomilov Ivanov to our Advisory Board. He brings outstanding medical practice experience & understanding of the clinical practices in Europe. He will guide the Clinical Trials for the ITV-1 therapeutic in accordance with EMA requirements. #ITV1

16

125

502

Gaurav Chandra M.D.

@drgauravchandra

3 years

Enzolytics takes rapid strides in achieving one of the many milestones. $ENZC #HIV #ENZC #OTCQB #COVID19 #EMA #FDA #patents ITV-1

Enzolytics Finalizes Documentation with International Medical Partners, Ltd for Clinical Trials and...

COLLEGE STATION, TX / ACCESSWIRE / March 16, 2021 / Enzolytics, Inc. (OTC Markets "ENZC" or the "Company") today announced the formalization of corporate legal documents pursuant to Articles of...

finance.yahoo.com

23

133

487

Gaurav Chandra M.D.

@drgauravchandra

1 year

This is truly impressive #ENZC and will empower #BGEN to develop multiple monoclonal antibodies, significantly boosting our drug discovery capabilities.This will broaden our intellectual property portfolio & enhance our #AI platform for P4 medicine.

Enzolytics, Inc. Reports Amendment to Non-Binding Term Sheet with the Special Purpose Acquisition...

Enzolytics, Inc. (OTC PINK:ENZC) (https://enzolytics.com/).

finance.yahoo.com

54

138

486

Gaurav Chandra M.D.

@drgauravchandra

3 years

Identification of new #SARSCoV2 #Variant C.1.2 in South Africa.Mutates twice as fast and raises very serious concerns regarding vaccine evasion.We have to start focussing on conserved targets & not chase mutations. #enzc #Mabs #C12 #DeltaVariant

The continuous evolution of SARS-CoV-2 in South Africa: a new lineage with rapid accumulation of...

SARS-CoV-2 variants of interest have been associated with increased transmissibility, neutralization resistance and disease severity. Ongoing SARS-CoV-2 genomic surveillance world-wide has improved...

www.medrxiv.org

32

150

487

Gaurav Chandra M.D.

@drgauravchandra

3 years

To accomplish great things, we must dream and act; not only plan but also believe and execute. So this independence day, let us resolve to create a beautiful tomorrow for everyone. @enzolytics Happy Independence Day. #HappyIndependanceDay #cure #ENZC #COVID19 #HIV

19

95

485

Gaurav Chandra M.D.

@drgauravchandra

3 years

Congratulations to our partners Samsung Biologics as they move quickly with biosimilars for oncology and autoimmune diseases and expand their portfolio. #enzc

Samsung Biologics to acquire Biogen’s stake in Samsung Bioepis

Samsung Biologics has entered an agreement to acquire Biogen’s stake in the Samsung Bioepis joint venture (JV) for up to $2.3bn.

www.pharmaceutical-technology.com

17

106

488

Gaurav Chandra M.D.

@drgauravchandra

3 years

Very excited to have Dr. Suraj Kumar Saggar join our Advisory Board of Enzolytics Inc.His appointment complements #enzc 's growth as multiple products move towards clinical trials and patient use

23

116

491

Gaurav Chandra M.D.

@drgauravchandra

3 years

Enzolytics Inc. announces the appointment of Steve Sharabura as President of the Company's wholly owned subsidiary RobustoMed, Inc. that will focus on revenue and partnership expansion in Brazil and Costa Rica. #ENZC #ITV1 via @Yahoo

Enzolytics Announces the Appointment of Steve Sharabura as President of its Wholly Owned Subsidiary...

COLLEGE STATION, TX / ACCESSWIRE / July 26, 2021 / Enzolytics, Inc. (OTC PINK:ENZC) ("Enzolytics" and the "Company") announced today the appointment of Steve Sharabura as President of the Company's...

finance.yahoo.com

14

112

478

Gaurav Chandra M.D.

@drgauravchandra

3 years

1. We have made great progress and now have multiple platforms for providing multiple therapeutics for the treatment of many diseases. These platforms will cover an extensive range of diseases. #enzc #revenue #hiv #sarscov2 #uplist

17

140

476

Gaurav Chandra M.D.

@drgauravchandra

2 years

IPF Immune website soon. Let us start helping people. #ENZC #IPFIMMUNE

45

120

483

Gaurav Chandra M.D.

@drgauravchandra

3 years

We thank everyone for the overwhelming support as we march forward. #ENZC #HIV #SARS_CoV_2 #NIH #patent #monoclonal #ITV1 #COVID19 #EMA #FDA #ENZCtherapeutics #CDC #EmergingVariants #AI #universal #durable #broadly #neutralizing #mAbs

30

136

469

Gaurav Chandra M.D.

@drgauravchandra

3 years

As per our predictions, Cell published data indicate SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies induced by infection and vaccination. We have to target conserved sites. #ENZC #variantsofconcern #pandemic @CellCellPress

31

104

466

Gaurav Chandra M.D.

@drgauravchandra

3 years

#Deltacron #omicron -like genetic signatures within the delta genomes. #Flurona infection with the influenza virus and SARS-CoV-2. The mutations are happening at a much faster rate; focus has to be on therapy that prevents virus escape. #ENZC #AI #Mabs

Cyprus reportedly discovers a Covid variant that combines omicron and delta

The strain is being called "deltacron."

www.cnbc.com

43

121

470

Gaurav Chandra M.D.

@drgauravchandra

3 years

As we complete a yr let me compliment the #ENZC family. We started with a few but now we are many in numbers, breakthroughs, partners, and clinical products. The future is bright as we march forward fulfilling milestones #partners #microbiome #AI #HIV #SARSCoV2 #ITV #IPF #IP

35

108

471

Gaurav Chandra M.D.

@drgauravchandra

2 years

At Enzolytics, we firmly believe the best is yet to come and look forward to the future unfolding. #ENZC

Gaurav Chandra M.D.

@drgauravchandra

3 years

Never lose sight of how far we have come, what we have achieved, the current and upcoming partnerships, upcoming milestones, and catalysts for the company. ALL the milestones will be achieved. Don't chase daily prices. We have a plan for success. #ENZCSTRONG #ENZC

56

169

685

48

110

461

Gaurav Chandra M.D.

@drgauravchandra

3 years

Enzolytics continues to meet all the milestones. More to come as we make rapid strides. #ENZC #HIV #COVID19

47

103

457

Gaurav Chandra M.D.

@drgauravchandra

3 years

As disclosed on our website we continue to work on therapeutic (CoronaVirus) monoclonal antibodies and phage display anti-SARS-CoV-2 vaccine. We strive to provide regular updates via press releases. #ENZC $ENZC #COVID19 #universal #durable #mAbs #vaccine #EmergingVariants

24

130

456

Gaurav Chandra M.D.

@drgauravchandra

3 years

We have engaged TEN Associates LLC in disseminating information about Enzolytics and our progress, to market makers, the brokerage community, individual investors, the media, and the public. #enzc

35

108

449

Gaurav Chandra M.D.

@drgauravchandra

3 years

Thank you for the overwhelming support. We continue to be transparent and accountable and will continue to provide updates ONLY through OUR official press releases. We continue to make progress in the application of our multiple platforms including ITV-1 anti-HIV Therapy #ENZC

41

82

456

Gaurav Chandra M.D.

@drgauravchandra

2 years

If you aren't making waves, you aren't kicking hard enough. So let us continue to make waves by spreading the message loud and clear "we are winning, end of the story." #ENZC

Company News - Enzolytics

ENZOLYTICS ANNOUNCES THE SIGNING OF THE BUSINESS COMBINATION AGREEMENT WITH SAGALIAM ACQUISITION CORP (SAGA) COLLEGE STATION, TX / ACCESSWIRE / September 5, 2023/ Enzolytics, Inc. (OTC PINK: ENZC)...

enzolytics.com

58

138

462

Gaurav Chandra M.D.

@drgauravchandra

2 years

Enzolytics continues to make significant advancements in its multiple therapeutic platforms & outlines the technical aspects of implementing those programs & the Company's plans for the future.With purpose and Passion for Progress, we march forwards. #ENZC

Enzolytics, Inc. Reports Progress and Future Plans

Enzolytics continues to make significant progress in its multiple therapeutic platforms and outlines here the technical aspects of the implementation of those programs and the Company's plans for the...

www.nasdaq.com

21

124

453

Gaurav Chandra M.D.

@drgauravchandra

3 years

A vital part of an AI platform to identify novel therapeutic targets for the pandemic would be to evaluate the effects of Genetics, Nutrition, and Microbiome on the development of covid, severity of covid, and the development of long covid #AI #ENZC #COVID19 #microbiomeproject

9

116

451

Gaurav Chandra M.D.

@drgauravchandra

3 years

Utilizing Enzolytic's proprietary Artificial Intelligence (AI) methodology we identify conserved, immutable sites on HTLV-1 virus against which we will produce Fully Human anti-HTLV-1 Monoclonal Antibodies. #ENZC #AI #HTLV #AIplatform #Mab #COVID19

Enzolytics Announces the Discovery of Conserved, Immutable Target Sites on HTLV-1 and Plans To...

www.accesswire.com

18

122

440

Gaurav Chandra M.D.

@drgauravchandra

3 years

#Epsilon #variantofconcern , bears three mutations on Spike protein, confers resistance to neutralizing antibodies generated by mRNA vaccines or by #SARSCoV2 infection. Let us ONLY target immutable sites for a #cure and not chase #mutations #ENZC #AI #mabs

19

123

431

Gaurav Chandra M.D.

@drgauravchandra

3 years

@mc_stocktrader Only the tip of the iceberg.

36

74

443

Gaurav Chandra M.D.

@drgauravchandra

3 years

As we are approaching the end of the year, optimism governs our thoughts. So let us honor the Christmas spirit in our heart and keep it all the year. @Enzolytics wishes you a merry Christmas and the best for the upcoming Holiday Season! #ENZC #Christmas

31

64

438

Gaurav Chandra M.D.

@drgauravchandra

2 years

#ENZC strong and capable we keep marching forward. #ENZCfamily

Gaurav Chandra M.D.

@drgauravchandra

3 years

Never lose sight of how far we have come, what we have achieved, the current and upcoming partnerships, upcoming milestones, and catalysts for the company. ALL the milestones will be achieved. Don't chase daily prices. We have a plan for success. #ENZCSTRONG #ENZC

56

169

685

35

104

436

Gaurav Chandra M.D.

@drgauravchandra

3 years

Enzolytics continue to make great strides in the application of our multiple platforms for the production of therapeutics for treating infectious diseases. #ENZC #HIV #SARSCoV2 #Monoclonal #Antibodies #MILESTONES #Partnerships #Collaborations

Enzolytics Reports Progress On Its Multiple Therapeutics Platforms and Initiatives

COLLEGE STATION, TX / ACCESSWIRE / April 19, 2021 / Enzolytics, Inc. (OTC Markets "ENZC" or the "Company").

finance.yahoo.com

21

99

436

Gaurav Chandra M.D.

@drgauravchandra

2 years

Our next revenue-generating product, #IPFimmune , is the first stepping stone in a chain reaction, a catalyst that will lead to multiple innovative Clinical products. Many more to follow in 2022. #ITV1 #Africa #vmabs #diagnostics #AI #patents #ENZC #mab #partnerships #licensing

24

125

436

Gaurav Chandra M.D.

@drgauravchandra

3 years

2. #ENZC #AI analysis of isolates of the #Omicron Variant confirmed that the conserved epitopes are also FULLY conserved in the Omicron Variant. Enzolytics’ Monoclonal Antibodies are Fully Human, Universal, Durable and Broadly Neutralizing NOT affected by mutations. #SARS_CoV_2

57

165

433

Gaurav Chandra M.D.

@drgauravchandra

2 years

May the Christmas Season bring only happiness and happiness to you and your family. The gift of love. The gift of peace. The gift of joy. May all these be yours at Christmas. I wish you and your families a wonderful peaceful holiday season and a happy new year.

61

36

439

Gaurav Chandra M.D.

@drgauravchandra

2 years

Who says the sky is the limit with footprints on the moon. With immune boosters & multiple #AI -driven platforms diagnosing, preventing, & treating diseases, #ENZC continues its relentless pursuit to get clinical products to patients-limitless potential.

Enzolytics, Inc. Discusses the Significance and Revenue Potential of...

The Stock Day Podcast welcomed Enzolytics, Inc. (ENZC) (“the Company”), a drug development company committed to commercializing its proprietary proteins and monoclonal antibodies to treat debilitat...

audioboom.com

30

132

429

Gaurav Chandra M.D.

@drgauravchandra

1 year

Our dedication to revolutionizing drug discovery through the power of AI is exemplified through our recent partnership.Our AI platform is at the forefront of transforming healthcare by shifting it from a reactive approach to one that is predictive, preventive, personalized, and

28

87

438

Gaurav Chandra M.D.

@drgauravchandra

4 years

At Enzolytics, we go one step beyond by applying Artificial Intelligence to abrogate the harmful effects of the variations that might be more transmissible; more lethal than merely just "monitoring" and "identifying" the virus mutations. #ENZC #COVID -19

22

125

420

Gaurav Chandra M.D.

@drgauravchandra

1 year

We express our gratitude for our valued shareholders' continued and unwavering backing, especially amidst trying circumstances. Our commitment to pressing ahead with our plans and vision perseveres unwaveringly. With resolute determination, we forge ahead towards greater

75

83

434

Gaurav Chandra M.D.

@drgauravchandra

3 years

"Tragedy should be utilized as a source of matter what sort of difficulties, how painful experience is, if we lose our hope, that's our real disaster.”During this pandemic Enzolytics continues to be the beacon of hope #enzc #COVID19India #vaccine #mAb

34

84

420

Gaurav Chandra M.D.

@drgauravchandra

3 years

"we are certainly on the move onwards and upwards" -Martin Smith #ENZC #AI #iamintel #ai4good #HIV #COVID19 #mAb #leadership

29

89

418

Gaurav Chandra M.D.

@drgauravchandra

3 years

#worldmicrobiomeday #ENZC continues to focus on envisioned consortium using #AI to assess the effect of Genetics, Nutrition, & #Microbiota on infectious ds. Imbalance of the microbiome has a role in the magnitude of #COVID severity and development of #LongCovid @Naveen_Jain_CEO

15

86

411

Gaurav Chandra M.D.

@drgauravchandra

3 years

@IntelPolicy @intel @enzolytics #AI is shaping healthcare,P4 medicine is developing with tailor-made diagnostic, treatment, and prevention approaches using the individual characteristics of patients.The idea of “one-size-fits-all” disappears.We are very excited to be a part of this future #ENZC #microbiome

19

97

416

Gaurav Chandra M.D.

@drgauravchandra

3 years

NPI boasts over 100 years of combined experience in the distribution and retail markets. Their experts have worked in and had success stories with virtually EVERY major retail channel in the United States. #REVENUE #IPFIMMUNE Enzolytics IPF Immune ™

Enzolytics IPF Immune™ Helps Fight Infections

New Dietary Supplement That Enhances Your Immune System Will Soon Be Available in the U.S.

www.einnews.com

34

100

419

Gaurav Chandra M.D.

@drgauravchandra

3 years

@iCoreCapital Science will win because it works. The future is bright. Keep up the faith and belief. #ENZCstrong #ENZC

31

79

413

Gaurav Chandra M.D.

@drgauravchandra

3 years

The Use of Artificial Intelligence for Social Good | #Intel #Enzolytics #AI #ENZC @enzolytics @cliftonroberts @jameshicks Let us build the future onwards and onwards

The Use of Artificial Intelligence for Social Good | #Intel #Enzoly...

While each video series on INFOtainment News has a specific target and focus - One of our primary goals is to Enlighten, Entertain and Educate.Topic: The Use...

www.youtube.com

24

114

407

Gaurav Chandra M.D.

@drgauravchandra

3 years

"For when people get caught up with that which is right, and they are willing to sacrifice for it, there is no stopping point short of victory." So let us take a moment to remember and reflect on what he stood for. Happy MLK Day! #MLKDay Stay strong #ENZC family we are close

11

90

412

Gaurav Chandra M.D.

@drgauravchandra

3 years

#NuVariant B.1.1.529 mutations overall and more than 30 on the spike protein, #vaccines target.10 mutations compared to two for the Delta variant in RBD. In 2 weeks, cases in SA it went from 0 to 1000/ day.Crucial to target immutable sites on the #Virus #AI #ENZC #SARSCoV2

29

110

404

Gaurav Chandra M.D.

@drgauravchandra

2 years

Congratulations to our partner Samsung Biologics, who is envisioning development into a biopharmaceutical firm with three pillars ― CDMO, biosimilars, and new drug development. #ENZC

Samsung Biologics eyes global market with acquisition of Samsung Bioepis: CEO

Samsung Biologics, the biotech arm of Korea's Samsung Group, aims to expand its presence in the global market through full ownership of Samsung Bioepis, its chief executive said Tuesday.

m.koreatimes.co.kr

30

117

412

Gaurav Chandra M.D.

@drgauravchandra

1 year

At Biogenysis, our primary focus is on developing monoclonal antibodies, which has resulted in great success for us. We can expand our programs through the SPAC agreement and bring many more monoclonal antibodies to market. Our intellectual property portfolio includes

33

90

415

Gaurav Chandra M.D.

@drgauravchandra

3 years

@jameshicks Thanks James.We look forward to an exciting phase for Enzolytics.Lots to talk about milestones, partnerships,Intellectual Property portfolio, Ecobiotic drugs and microbiome as we enter an exciting phase of exponential growth for Enzolytics.Onwards and upwards. #ENZCSTRONG #enzc

34

93

402

Gaurav Chandra M.D.

@drgauravchandra

3 years

@mc_stocktrader What was once unimaginable at Enzolytics we are transforming into reality. We have only touched the tip of the iceberg thus far. Expect great things... #ENZCSTRONG #ENZC

16

92

405

Gaurav Chandra M.D.

@drgauravchandra

2 years

Enzolytics continues to take massive strides in strengthening multiple intellectual portfolios covering the waterfront on viruses-diagnostics, prognostics, and therapeutics. #AIPLATFORM #ENZC #PATENT #Diagnostics #Prognostics #Mabs #HIV #SARSCoV2 #AI

11

114

409

Gaurav Chandra M.D.

@drgauravchandra

3 years

Gut microbiome can predict COVID-19 mortality rates. Collinsella transforms the gut's bile acids into ursodeoxycholic acid, inhibiting the cytokine storm in #SARSCOV2 . #Microbiome #AI We need to incorporate gut microbiome in our management #microbiome #AI

Intestinal bacteria could be behind Japan's low COVID deaths, study says

Many have searched for an X-factor to explain differing mortality rates between countries, and Nagoya University scientists think part of the answer might be in the gut.

www.japantimes.co.jp

21

95

398

Gaurav Chandra M.D.

@drgauravchandra

2 years

We can, and we will let us go. We keep pushing forward towards success. #audited #ENZC #ENZCstrong #domino #ONEleadstomanymore

31

96

406

Gaurav Chandra M.D.

@drgauravchandra

3 years

Thanksgiving is a chance to cherish and embrace those who enrich our lives. May your homes be filled with laughter and happiness, and this day be a lovely reminder of the beautiful things in life @Enzolytics sends you warm wishes for a #HappyThanksgiving #ENZC #ENZCstrong

29

49

402